A double-blind, randomized, vehicle-controlled, parallel group, multicenter study to assess the efficacy and safety of a topical gel product containing ketoconazole USP 2% in the treatment of seborrheic dermatitis

doi:10.1016/j.jaad.2004.10.495

A double-blind, randomized, vehicle-controlled, parallel group, multicenter study to assess the efficacy and safety of a topical gel product containing ketoconazole USP 2% in the treatment of seborrheic dermatitis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2004.10.495 ◽

2005 ◽

Vol 52 (3) ◽

pp. P122

Keyword(s):

Multicenter Study ◽

Seborrheic Dermatitis ◽

Efficacy And Safety ◽

Double Blind ◽

Topical Gel ◽

Parallel Group

Download Full-text

Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

Epilepsia ◽

10.1111/epi.13993 ◽

2018 ◽

Vol 59 (2) ◽

pp. 479-491 ◽

Cited By ~ 37

Author(s):

Eugen Trinka ◽

Elinor Ben-Menachem ◽

Pedro A. Kowacs ◽

Christian Elger ◽

Birgit Keller ◽

...

Keyword(s):

Controlled Release ◽

Multicenter Study ◽

Phase Iii ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Parallel Group

Download Full-text

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of Urology ◽

10.1016/j.juro.2008.11.125 ◽

2009 ◽

Vol 181 (4) ◽

pp. 1764-1772 ◽

Cited By ~ 68

Author(s):

David R. Staskin ◽

Roger R. Dmochowski ◽

Peter K. Sand ◽

Scott A. MacDiarmid ◽

Kim E. Caramelli ◽

...

Keyword(s):

Overactive Bladder ◽

Multicenter Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Topical Gel

Download Full-text

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Multicenter Study

Yearbook of Urology ◽

10.1016/s0084-4071(10)79446-x ◽

2010 ◽

Vol 2010 ◽

pp. 36-37

Author(s):

E.S. Rovner

Keyword(s):

Overactive Bladder ◽

Multicenter Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Topical Gel

Download Full-text

Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: A randomized, double-blind, parallel-group, placebo-controlled, multicenter study

Clinical Therapeutics ◽

10.1016/j.clinthera.2010.01.016 ◽

2010 ◽

Vol 32 (1) ◽

pp. 34-43 ◽

Cited By ~ 36

Author(s):

Yoshinobu Higashi ◽

Takehito Kiuchi ◽

Kenichi Furuta

Keyword(s):

Multicenter Study ◽

Safety Profile ◽

Methyl Salicylate ◽

Adult Patients ◽

Efficacy And Safety ◽

Muscle Strain ◽

Double Blind ◽

Parallel Group

Download Full-text

Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

SLEEP ◽

10.1093/sleep/31.1.79 ◽

2008 ◽

Vol 31 (1) ◽

pp. 79-90 ◽

Cited By ~ 136

Author(s):

Andrew D. Krystal ◽

Milton Erman ◽

Gary K. Zammit ◽

C. Soubrane ◽

Thomas Roth

Keyword(s):

Multicenter Study ◽

Extended Release ◽

Primary Insomnia ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Term Efficacy ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793482011 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793480560 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Alana M Murphy

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text